الصفحة الرئيسية>>Signaling Pathways>> Microbiology & Virology>> SRPK>>SPHINX

SPHINX

رقم الكتالوجGC65981

SPHINX هو مثبط انتقائي SRPK1 بقيمة IC50 تبلغ 0.58 μ ؛ M. يقلل SPHINX بشكل فعال من تكوين الأوعية الدموية المشيمية (CNV) في الجسم الحي. يمكن استخدام SPHINX في البحث عن (الضمور البقعي المرتبط بالعمر) AMD.

Products are for research use only. Not for human use. We do not sell to patients.

SPHINX التركيب الكيميائي

Cas No.: 848057-98-7

الحجم السعر المخزون الكميّة
10mM (n 1mL DMSO)
277٫00
متوفر
5mg
252٫00
متوفر
10mg
378٫00
متوفر
25mg
702٫00
متوفر
50mg
1125٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

IC50: 0.58 μM (SRPK1)[1]

SPHINX is a selective SRPK1 inhibitor with an IC50 value of 0.58 μM. SPHINX effectively reduces Choroidal Neovascularization (CNV) in vivo. SPHINX can be used for the research of (age-related macular degenaration) AMD[1].

SPHINX (10 μM; 2 h) affects EGF-induced phosphorylation of SRSF1 and SRSF2[1].
SPHINX (5 μM; 24 h) reduces the expression of VEGF165 relative to GAPDH control either in primary RPE and ARPE-19 cell lines[1].

Western Blot Analysis[1]

Cell Line: ARPE-19 cell line
Concentration: 10 μM
Incubation Time: 2 hours
Result: Blocked EGF-induced phosphorylation of SRSF1 and SRSF2.

SPHINX (10 ng; i.o. on laser photocoagulation day 0 and day 7) affects neovascular growth in vivo[1].
SPHINX (25 ng; i.o. on laser photocoagulation day 0 and day 7) affects the CNV area in CNV rats[1].

Animal Model: C57/B6 mice with laser-induced CNV[1]
Dosage: 10 ng
Administration: Intraocular injection; 10 ng on laser photocoagulation day 0 and day 7
Result: Significantly reduced neovascular growth compared with saline-injected controls.
Animal Model: Norway Brown rats with laser-induced choroidal neovascularization[1]
Dosage: 25 ng (10 ng/uL)
Administration: Intraocular injection; 25 ng (10 ng/uL) on laser photocoagulation day 0 and day 7
Result: Significantly reduced the CNV area compared with saline injected controls.

مراجعات

Review for SPHINX

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SPHINX

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.